Get the app
US › Healthcare

PetMed Express Inc (PETS)

US · Healthcare · Pharmaceutical Retailers

$1.18-3.28%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$41.0M
Revenue YoY
-19.9%
Net profit
$-6.1M
EPS
$-0.28
EPS estimate
$0.12
Net margin
-15.0%

EPS came in at -0.28 against a street estimate of 0.12 — a miss of 333.3%.

Key statistics

Market cap
$27.9M
Forward P/E
16.7
P/B
1.46
Book value
$1.09
EPS (TTM)
$-1.38
52-week high
$4.10
52-week low
$1.27
50-day MA
$1.70
200-day MA
$2.28
Beta
0.84

Analyst view

Analysts rate PetMed Express Inc a strong sell (0 buy, 0 hold, 1 sell out of 1) with an average price target of $1.40.

Shareholding

Insiders
17.78%
Institutions
37.38%

Largest institutional holders

FundStake
Renaissance Technologies Corp5.22%
Vanguard Capital Management, LLC3.82%
BlackRock Inc2.62%
Federated Hermes Inc0.98%
Geode Capital Management, LLC0.94%
Steel Partners Holdings LP0.89%
UBS Group AG0.64%
T. Rowe Price Associates, Inc.0.60%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for PetMed Express Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.